⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocksUnlock stocks

District of Columbia panels weigh legalizing marijuana sales

Published 10/30/2014, 05:07 PM
District of Columbia panels weigh legalizing marijuana sales

By Lacey Johnson

WASHINGTON (Reuters) - Washington lawmakers took a step toward legalizing the sale of marijuana in the U.S. capital on Thursday, holding a hearing on rules and taxes ahead of a referendum next week.

The proposed legislation to regulate marijuana sales in the District of Columbia is part of a sharp shift in U.S. public opinion in the past several years that has pushed legalized pot toward the mainstream.

Advocates at the hearing said the legal sale of marijuana was a top civil rights issue since blacks were far more likely to be arrested for pot possession than people of other races.

"It is time to end the failed experiment of marijuana prohibition. It has ... made criminals out of otherwise law-abiding citizens," Stacia Cosner, deputy director of the advocacy group Students for Sensible Drug Policy, told the joint hearing of the council's finance and business committees.

The proposal would legalize marijuana possession and private consumption for people 21 and older. Marijuana sales would be regulated by the city's Alcoholic Beverage Regulation Administration and taxed similarly to alcohol.

Under the law proposed by independent Councilman David Grosso, marijuana sold for recreational purposes would be taxed at 15 percent. Medical marijuana would be taxed at 6 percent.

Non-medical marijuana revenue would go into a fund that supports public services, such as youth programs and drug prevention education. An NBC4/Washington Post/Marist poll last month showed Washington voters backed legalization by a two-to-one margin.

Nov. 4 ballot initiatives in the District of Columbia, Oregon and Alaska will decide on legalizing marijuana, and they could join the states of Colorado and Washington. Decriminalization of pot in the District of Columbia took effect in July.

More than 30 activists and policy experts testified on Thursday, and they overwhelmingly favored Grosso's bill.

But Lanre Falusi, a pediatrician, said legalization would increase access to the drug. "A growing number of medical studies are showing the true dangers of marijuana," she said, and the bill would put minority youth in poverty at risk.

Grosso responded, "I don't think you can do more harm, in the District of Columbia or in this country, than putting them behind bars."

© Reuters. A medical marijuana user smells a jar of marijuana at the medical marijuana farmers market in Los Angeles

Marijuana reform in Washington could face scrutiny from the U.S. Congress, which has constitutional oversight over the capital.

(Reporting by Ian Simpson; Editing by Mohammad Zargham)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.